Central Trust Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Central Trust Company’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$12K	–	1155
2020 Q4	$12K	Buy	100 +30	+43%	+$3.36K	﹤0.01%	881
2020 Q3	$7K	Hold	70	–	–	﹤0.01%	911
2020 Q2	$9K	Sell	70 -225	-76%	-$25.5K	﹤0.01%	857
2020 Q1	$26K	Buy	295 +225	+321%	+$23.8K	﹤0.01%	721
2019 Q4	$7K	Sell	70 -115	-62%	-$12.9K	﹤0.01%	1009
2019 Q3	$21K	Hold	185	–	–	﹤0.01%	790
2019 Q2	$32K	Hold	185	–	–	﹤0.01%	725
2019 Q1	$31K	Hold	185	–	–	﹤0.01%	708
2018 Q4	$18K	Buy	+185	New	+$24.3K	﹤0.01%	792
2018 Q3	–	Sell	-10	Closed	-$1K	–	1317
2018 Q2	$1K	Buy	+10	New	+$1.42K	﹤0.01%	1239

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Central Trust Company's GWPH Position: Q1 2021 in Review

Central Trust Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 100 shares — an estimated $12K sold.

Central Trust Company first reported a position in GWPH in Q2 2018 and held it in 10 quarters. The position peaked at $32K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Central Trust Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Central Trust Company sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $12K.
Central Trust Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 10 quarters.
Central Trust Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $32K in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Central Trust Company's 13F filing for Q1 2021, filed 23 Apr 2021.